MedTrace Logo

Effect of Addition of Fentanyl or Dexamethasone or Both to Bupivacaine in Paravertebral Block for Patients Undergoing Major Breast Surgery

NCT03480308 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2021-02-23

No results posted yet for this study

Summary

This study evaluated the analgesic efficacy of fentanyl and dexamethasone in combination with bupivacaine for single-shot paravertebral block (PVB) in patients undergoing major breast surgery.

Conditions

  • Paravertebral Block

Interventions

DRUG

Fentanyl

Patients will receive bupivacaine (0.5%) 20 ml , fentanyl 1 μg/kg in paravertebral block

DRUG

Dexamethasone

Patients will receive bupivacaine (0.5%) 20 ml , Dexamethasone 4mg in paravertebral block

DRUG

Bupivacaine

Bupivacaine

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Amonios khalil · Faculty of medicine-Assiut university-Egypt

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2019-04-01
Completion
2021-03-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03480308 on ClinicalTrials.gov